Phase I clinical trial using peptide vaccine for human vascular endothelial growth factor receptor 2 in combination with gemcitabine for patients with advanced pancreatic cancer

Motoki Miyazawa, Hiroki Yamaue, Seiko Hirono et al.|Cancer Science|2009

Cited by 117